Related Experiment Video
Updated: Jul 8, 2025
14:04
Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
17.3K
All you need to know about VIPoma: Review on the latest studies.
1Faculty of Medicine, Riga Stradins University, 16 Dzirciema Street, Riga LV-1007, Latvia.
Presse Medicale (Paris, France : 1983)
|December 18, 2023
Summary
Vasoactive intestinal peptide secreting tumors (VIPomas) are rare neuroendocrine tumors causing severe symptoms. This review covers their latest epidemiology, diagnosis, and treatment strategies.
Area of Science:
- Endocrinology
- Oncology
- Gastroenterology
Background:
- Vasoactive intestinal peptide secreting tumor (VIPoma) is a rare, often malignant, neuroendocrine tumor.
- Characterized by watery diarrhea, hypokalemia, and achlorhydria due to excessive VIP secretion.
Purpose of the Study:
- To provide an insight into the latest research on VIPoma.
- Covering epidemiology, pathophysiology, diagnostics, and treatment.
Main Methods:
- Review of current literature on VIPoma.
- Analysis of diagnostic methods including symptoms, lab tests, imaging, and immunohistochemistry.
Main Results:
- VIPomas are diagnosed through a combination of clinical presentation, laboratory findings, and imaging.
- Treatment involves fluid and electrolyte correction, somatostatin analogs, surgery, and chemotherapy.
Conclusions:
- Early diagnosis and comprehensive management are crucial for VIPoma patients.
- Further research is needed to improve understanding and therapeutic outcomes for VIPoma.
